Science Corp
Last verified 2026-05-07. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $230.0Mattributed |
|---|---|
| Latest round | series-d+, $230.0M, 2026-03-01attributed |
| Founded | 2021 |
| Headquarters | USA |
| Industry | bio |
| Stage | series-b+ |
| Website | sciencecorp.com |
Science Corporation develops neural-interface devices led by PRIMA, a retinal implant restoring functional vision in macular-degeneration patients, plus biohybrid interfaces. It treats AMD, retinitis pigmentosa, and Stargardt patients while serving neural-engineering labs. PRIMA results were published in NEJM.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-03-01 | series-d+ | $230.0M | khosla |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series D+, $230.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $230.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | sciencecorp.com, read 2026-05-07 |
| Description | self-reported | sciencecorp.com, read 2026-05-07 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.